See also this year's filing and all EDGAR filings for this company.
PDF Report 0000707511_2019_REGENERX_BIOPHARMACEUTICALS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000707511')"} |
Graph
Absolute values for 0000707511, REGENERX BIOPHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 273,870 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,418 |
| 3 | remainder_Assets | 5,752 |
| 4 | LiabilitiesCurrent | 315,006 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 2,178,087 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,311,993 |
| 9 | ResearchAndDevelopmentExpense | 81,043 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 69,667 |
| 12 | remainder_NetIncome | -670,184 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 281,040 |
| 1 | Liabilities | 2,493,093 |
| 2 | Expenses | 1,393,036 |
| 3 | Revenues | 69,667 |
| 4 | StockholdersEquity | -2,212,053 |
| 5 | NetIncome | -1,993,553 |
| 6 | ComprehensiveNetIncome | -1,993,553 |
| 7 | BaseVar | 2,453,510 |
| 8 | EconomicCapitalRatio | -4.18 |